Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) becomes resistant to a drug targeting the abnormal protein in the cancer…
More: continued here
Filed under: Lung Cancer on January 23rd, 2012 | No Comments »
New research published in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs. The study was led by investigators with the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J…
More: […]
Filed under: Lung Cancer on January 23rd, 2012 | No Comments »
Smoking may be associated with the development of molecular features of cancer in the large airway epithelium. In the small airway epithelium, molecular cancerization is associated with development of chronic obstructive pulmonary disease, according to recent data…
More: continued here
Filed under: Lung Cancer on January 11th, 2012 | No Comments »
Use of statins may influence susceptibility to or the progression of interstitial lung disease (ILD) in smokers, according to a new study…
More: continued here
Filed under: Lung Cancer on January 10th, 2012 | No Comments »
Multicentric carcinogenesis with the same genetic mutation appears to occur in lung adenocarcinoma, according to data presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine, held Jan. 8-11, 2012…
More: continued here
Filed under: Lung Cancer on January 10th, 2012 | No Comments »
Lung Cancer Alliance (LCA) President Laurie Fenton-Ambrose predicted that because of major breakthroughs this year in screening, treatment and research, 2011 will be defined as the turning point year for lung cancer…
More: continued here
Filed under: Lung Cancer on January 3rd, 2012 | No Comments »
Lung cancer takes a heavy toll, contributing to more cancer deaths in the United States each year than breast, prostate and colon cancers combined. Contributing to this poor prognosis is the fact that lung cancer often goes undetected until the disease has reached an advanced and more difficult-to-treat stage…
More: continued here
Filed under: Lung Cancer on January 3rd, 2012 | No Comments »
Tecnalia, through the Interreg project Medisen, is contributing to develop biosensors capable of detecting the presence of tumour markers of lung cancer in exhaled breath…
More: continued here
Filed under: Lung Cancer on December 24th, 2011 | No Comments »
The International Association for the Study of Lung Cancer (IASLC) has taken a proactive role in advancing discussions with the international lung cancer community on how we should take lung cancer screening forward…
More: continued here
Filed under: Lung Cancer on December 20th, 2011 | No Comments »
The cancer-causing potential of fetal exposure to carcinogens can vary substantially, a recent study suggests, causing different types of problems much later in life depending on the stage of pregnancy when the fetus is exposed. The research sheds further light on the way in which toxic damage early in life can later manifest themselves as […]
Filed under: Lung Cancer on December 20th, 2011 | No Comments »